NeuroXess
PrivateLast Round
Series A
Extension
Jul 7, 2026
Total Funding Raised
$15.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NeuroXess is a life sciences company that develops invasive brain-computer interface (BCI) technology, including flexible electrodes, medical equipment, and software, for medical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroXess Comparables
Compare NeuroXess with similar companies based on industry and business-model similarity.
NeuroXess Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 7, 2026 | ||||
| Series B | Sep 1, 2025 | ||||
| Series A | Dec 28, 2022 | ||||
| Seed | Jan 11, 2022 |
NeuroXess Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series A, Seed |
| Shanghai Sailing Capital | Series A |
| Zhongping Capital | Series A |
| Sequoia Capital | Seed |
| Yonghua Capital | Seed |
| Shanda Capital | Seed |
| Shanda Group | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 36, 720% of headcount.
- Jul 13, 2026
Open roles increased to 30, 600% of headcount.
NeuroXess Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroXess's valuation, stock price, and market status.